The American College of Medical Genetics and Genomics (ACMG) put forth a Points-to-Consider document: “Is there Evidence to Support BRCA1/2 and Other Inherited Breast Cancer Genetic Testing for all Breast Cancer Patients?” The document discusses:
1) Current data to support testing in breast cancer patients
2) Factors that should guide testing such as age, tumor characteristics, and family history
Currently there is insufficient evidence to recommend testing in all women with breast cancer. However, as more information becomes available, testing criteria may change. Professional organizations need to work together to harmonize and implement evidence-based recommendations.
Check It out at: https://www.nature.com/articles/s41436-019-0712-x